LSX Nordic Congress-1


 29-30 AUGUST 2018 | NASDAQ OFFICE | STOCKHOLM

DOWNLOAD THE BROCHURE
BOOK YOUR TICKET NOW

2018 Event Partners

ABOUT THE 2018 Nordic Congress


The LSX Nordic Congress is a high-calibre, senior executive conference and partnering event providing the education, strategies, solutions, and contacts that life science companies need to enable more effective investment, business planning and partnering within their businesses.

The Nordic region has long produced world-leading science and innovation and Nasdaq Nordic is one of the leading hubs for biotech companies in Europe, strengthened further by a hugely active IPO market over the last two years. However, growth and venture funding is lacking compared with other hubs and listed Nordic companies face a number of specific challenges in their ongoing funding, growth, development and internationalisation.

With our relentless focus on quality peer-to-peer discussion, high-level networking and partnering, unique formats and a vetted, high-calibre audience, we will bring together the people that matter to the future of life sciences in the Nordic region to address these challenges and work towards actionable outcomes to help it flourish.

LEARN MORE

 

SATELLITE AND ANCILLARY FORUMS

                     LSX Nordic Final.png                           CEO Forum-2.png                              Investable-4.png                     IPO Bootcamp 2018.png

        VIEW THE ADVANCED BROCHURE FOR:

                                                          Provisional Agenda and Invited Speakers
                                                           Ancillary Forums and Events
                                                          Reasons To Attend
                                                          

DOWNLOAD THE BROCHURE

Nordic Congress Download Brochure.png

CONFIRMED SPEAKERS

Ingrid Teigland

Ingrid Teigland Akay
Managing Partner, Hadean Ventures

Per Andersson

Per Andersson
CEO, Xspray

Rasmus Beedholm-Ebsen,

Rasmus Beedholm-Ebsen
Senior Advisor - Life Sciences, Invest in Denmark, Ministry of Foreign Affairs of Denmark

Mats Blom

Mats Blom
CFO, Zealand Pharma

Adam Bruce

Adam Bruce
Founder and Executive Board Member, Tikomed

Aris Constantinidis

Aris Constantinidis
General Partner, Kreos Capital

Don deBethizy

Don deBethizy
Chairman, Saniona

Viktor Drvota

Viktor Drvota
CEO, Karolinska Development

Goran Forsberg

Goran Forsberg
CEO, Cantargia

Miriam Frieden

Miriam Frieden
Vice President R&D Innovation Sourcing, Novo Nordisk

Mats Grahn

Mats Grahn
CEO, Immunovia

Ragnar Hellenius

Ragnar Hellenius
Partner, PAI Partners

Jan-Olof Jacke

Jan-Olof Jacke
CEO/President, AstraZeneca AB

Adam Kostyál

Adam Kostyál
SVP, Listing Service, Europe, Nasdaq

Christine Lind

Christine Lind
President and CEO, Medivir AB

Søren Møller

Søren Møller
Managing Partner, Novo Seeds

Jenni Nordborg

Jenni Nordborg
National Coordinator Life Sciences, Government Offices of Sweden

Nina Rawal, Head of Life Sciences, Industrifonden

Nina Rawal
Head of Life Sciences, Industrifonden

Åsa Riisberg

Åsa Riisberg
Partner and Head of Healthcare Sector, EQT Partners

 Julie Silber, Managing Partner, The Blueshirt Group

Julie Silber
Managing Partner, The Blueshirt Group

Ulrica Slåne Bjerke

Ulrica Slåne Bjerke
Founder & CIO, Arctic Aurora LifeScience

Nikolaj Sørensen

Nikolaj Sørensen
CEO, Orexo

Mårten Steen, Partner, HealthCap

Mårten Steen
Partner, HealthCap

Nathalie ter Wengel

Nathalie ter Wengel
European Head External R&D and Innovation, Pfizer

Sten Verland, Senior Partner

Sten Verland
Senior Partner, Sunstone Capital

Christer Ahlberg, CEO, Sedana Medical

Christer Ahlberg
CEO, Sedana Medical

Mattias Häggblom, Portfolio Manager - Global Healthcare, Swedbank Robur

Mattias Häggblom
Portfolio Manager - Global Healthcare, Swedbank Robur

Semih Sen, Partner, Biolinka

Semih Sen
Partner, Biolinka

OFFICIAL EVENT PARTNER

Nasdaq17_313+BK.png                 

 PREVIOUS NORDIC CLIENTS AND PARTNERS

Investors LSX Nordic

2018 EVENT VENUE

Address: 

Nasdaq Stockholm
Tullvaktsvägen 15, 105 78 Stockholm, Sweden

CONTACT US

Address : Suite 132, The Business Design Centre, 52 Upper St, London, N1 0QH, UK

Email: info@biotechandmoney.com

Phone: +44 (0) 203 637 5908